
Catalent Releases Open Letter to Customers About Novo Holdings Acquisition
Catalent Affirms Commitment to Customers and Patients Amidst Novo Holdings Acquisition Alessandro Maselli to Remain President and CEO of Catalent Post-Acquisition Catalent, Inc. (NYSE: CTLT), a leader in the development…

BeiGene Gains CHMP Backing for TEVIMBRA® in First-Line Treatment of Gastric and Esophageal Cancers
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® in First-Line Treatment of Gastric, Gastroesophageal, and Esophageal Cancers BeiGene, a global oncology leader, has achieved a significant milestone with the European Medicines…

Bruker Unveils $100 High-Accuracy Plasma Proteome, Advancing Glycoproteomics and Metaproteomics
Bruker Unveils Groundbreaking $100 Plasma Proteomics Platform, Pioneering Advances in Glycoproteomics and Metaproteomics Bruker Corporation has announced a revolutionary leap in 4D-Proteomics™, offering deep, high-fidelity plasma proteomics for just $100…

NUCLIDIUM Begins Phase 1 Imaging of ⁶¹Cu Radiotracer for PSMA-positive Prostate Cancer
NUCLIDIUM Announces First Patient Imaged in Phase 1 Study of ⁶¹Cu Radiotracer for Prostate Cancer NUCLIDIUM has successfully imaged the first patient in its Phase 1 clinical trial evaluating ⁶¹Cu-NuriPro™…

bioAffinity Technologies Prices $2.66 Million Registered Direct Offering and Concurrent Private Placement
bioAffinity Technologies Announces $2.66 Million Registered Direct Offering and Concurrent Private Placement bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to developing noninvasive tests for early-stage cancer detection,…

Biological Lattice Industries Raises $1.8M Pre-Seed Funding to Democratize Biofabrication
Biological Lattice Industries Corp. (BLI), an innovator in biofabrication and life sciences, has closed a $1.8 million pre-seed funding round led by Greek venture capital firm Uni.Fund. Alongside this investment,…

32% of Life Science Teams Lack KPI Use for Investment Decisions in Customer Engagement
Trinity Life Sciences has introduced a new Omnichannel Reporting Suite, offering key promotional activity insights for stakeholders in the life sciences industry. The suite aims to address a significant gap,…

Ferring Pharmaceuticals Showcases Commitment to Fertility Care at 2024 ASRM Congress
Ferring Pharmaceuticals will present new research across four abstracts at the 2024 American Society for Reproductive Medicine (ASRM) Congress, taking place from October 19-23 in Denver, Colorado, and online. The…

Vertex to Present Phase 3 Data on Suzetrigine as a Pain Signal Inhibitor at ASA Meeting
Vertex Pharmaceuticals (Nasdaq: VRTX) announced that it will present Phase 3 data on suzetrigine, an investigational oral NaV1.8 pain signal inhibitor for moderate-to-severe acute pain, at the American Society of…

Audax Private Equity Acquires Avantor’s Clinical Services, Rebrands as Resonant Clinical Solutions
Audax Private Equity has acquired the clinical services division of Avantor, Inc. and rebranded it as Resonant Clinical Solutions (“Resonant”). Resonant comprises three established brands: EPL Archives, MESM, and Therapak,…

Scholar Rock Announces New Employee Inducement Grants Under Nasdaq Rule 5635(c)(4)
Scholar Rock Grants Inducement Equity Awards to New Employees Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to developing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other…

GE HealthCare, Foundations Pledge $1M to Enhance Health Outcomes in Milwaukee
The “Powering Milwaukee Forward” initiative is set to enhance access to essential services and maternal healthcare in vulnerable communities across Milwaukee. Launched by GE HealthCare (Nasdaq: GEHC), the GE HealthCare…


